WCN24-420 SAFETY AND EFFICACY OF ANIFROLUMAB IN IMMUNE COMPLEX AND APOL-1 ASSOCIATED LUPUS PODOCYTOPATHY by James Tumlin, Ryan Alex, Brad Rovin

Get full text

Targeting the Type I Interferon Pathway in Glomerular Kidney Disease: Rationale and Therapeutic Opportunities by James Tumlin, Brad Rovin, Hans-Joachim Anders, Eduardo F. Mysler, David R.W. Jayne, Tsutomu Takeuchi, Catharina Lindholm, Gudrun Weiss, Alessandro Sorrentino, Kevin Woollard, Nicola Ferrari

Get full text

WCN24-762 UPDATED RESULTS FROM THE RUBY-3 STUDY OF POVETACICEPT, AN ENHANCED DUAL BAFF/APRIL ANTAGONIST, IN AUTOANTIBODY-ASSOCIATED GLOMERULONEPHRITIS by James Tumlin, Sreedhar Mandayam, Arvind Madan, Frank Cortazar, Sang-Woong Han, Hemant Kulkarni, Jonathan Barratt, Brad Rovin, Hong Zhang, Rupert Davies, Amanda Enstrom, Heather Thomas, Jiahua Li, Stanford L. Peng, Harmeet Singh

Get full text

WCN24-756 POVETACICEPT, AN ENHANCED DUAL BAFF/APRIL ANTAGONIST, IN AUTOANTIBODY-ASSOCIATED GLOMERULONEPHRITIS by James Tumlin, Sreedhar Mandayam, Arvind Madan, Frank Cortazar, Sang-Woong Han, Hemant Kulkarni, Jonathan Barratt, Brad Rovin, Hong Zhang, Rupert Davies, Amanda Enstrom, Heather Thomas, Jiahua Li, Stanford L. Peng, Harmeet Singh

Get full text